News & Events

MK-1084 Shows Promise in KRAS G12C Colorectal Cancer

MK-1084 Shows Promise in KRAS G12C Colorectal Cancer

E. Shyam P. Reddy: Researchers Identified a New Biomarker to Predict Outcomes in KRAS G12C-Mutated NSCLC

E. Shyam P. Reddy: Researchers Identified a New Biomarker to Predict Outcomes in KRAS G12C-Mutated NSCLC

New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer

New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer

TTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancer

TTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancer

TTF1 recognized as key biomarker for superior KRAS G12C-mutated non-small cell lung most cancers

TTF1 recognized as key biomarker for superior KRAS G12C-mutated non-small cell lung most cancers

HMN 2025: How New biomarker could information finest use of KRAS inhibitors in lung cancer – healthmedicinet

HMN 2025: How New biomarker could information finest use of KRAS inhibitors in lung cancer – healthmedicinet

Lung Cancer Biomarker TTF-1 Guides KRAS-Targeted Therapy

Lung Cancer Biomarker TTF-1 Guides KRAS-Targeted Therapy

New biomarker may guide best use of KRAS inhibitors in lung cancer

New biomarker may guide best use of KRAS inhibitors in lung cancer

Biomarker May Guide KRAS Inhibitor Use in Lung Cancer

Biomarker May Guide KRAS Inhibitor Use in Lung Cancer

New Biomarker Offers Insight for Optimizing KRAS Inhibitor Therapy in Lung

New Biomarker Offers Insight for Optimizing KRAS Inhibitor Therapy in Lung